Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury.
Steiner N, Abdel Hamid A, Kronbichler A, Neuwirt H, Myslivecek M, Kollar M, Lachmanova J, Rysava R, Hruskova Z, Spicka I, Willenbacher W, Nachbaur D, Wolf D, Tesar V, Gunsilius E.
Steiner N, et al. Among authors: lachmanova j.
J Nephrol. 2021 Aug;34(4):1263-1270. doi: 10.1007/s40620-020-00939-2. Epub 2020 Dec 31.
J Nephrol. 2021.
PMID: 33382447
Free PMC article.